Press Digest: Wall Street Journal - August 21
PRESS DIGEST-Wall Street Journal - August 21 The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
- StarbucksSBUX.O will lay off more than 200 corporate staff, continuing a strategy to tighten its operations two years into a turnaround effort pursued by CEO Brian Niccol.
- Canada's minister in charge of U.S. trade Dominic LeBlanc said Ottawa and Washington are "very close" to finalizing an agreement, following a roughly three-hour meeting with senior trade officials in the Trump administration.
- James Hardie Industries JHA1.F, will sell its European Fermacell business to Swiss building-materials company Holcim HOLN.S for $980 million as it seeks to focus on higher-growth and higher-return markets.
- AbbottABT.N agreed to pay $670 million to resolve a lawsuit over its specialty formulas for premature infants as well as about 2,000 related claims.
(Compiled by Bengaluru newsroom)
Recent news on Abbott Laboratories
See all newsBrief: Abbott Announces Availability Of Panbio Covid-19/Flu A&B Self-Test In Canada
Perrigo to sell infant formula business to MeridianMade for up to $175 million
Brief: Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve Disease
Corrected: German startup NVision shows new path to quantum computing chips in Nature paper
Brief: Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve Replacement